This is a review about HER2, based on 59 published articles (read how Labome selects the articles), using HER2 antibody in experiments. It is aimed to help Labome visitors find the most suited HER2 antibody.
HER2 synonym: CD340; HER-2; HER-2/neu; HER2; MLN 19; NEU; NGL; TKR1; c-erb B2/neu protein; herstatin; metastatic lymph node gene 19 protein; neuro/glioblastoma derived oncogene homolog; neuroblastoma/glioblastoma derived oncogene homolog; p185erbB2; proto-oncogene Neu; proto-oncogene c-ErbB-2; receptor tyrosine-protein kinase erbB-2; tyrosine kinase-type cell surface receptor HER2; v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog

  • Calbiochem anti-Her2 Ab3 antibody was used in western blot and immunoprecipitation to identify LRIG1 as a novel negative regulator of the Met receptor and its role on opposing Met and Her2 synergyncbi, more
  • suppliernumreagent link
    Life Technologies Corporation2HER2 antibody
    EMD Millipore1HER2 antibody
    WILEX Inc.1
    Cell Signaling Technology1HER2 antibody
    Dako19HER2 antibody
    Leica Microsystems7
    Roche Applied Science2
    Biogenex1
    Nichirei Biosciences Inc.1
    Table 1. HER2 antibody immunohistochemistry.
  • Calbiochem ErbB2 antibody was used in western blot to study the expression and role of Nrdp1 in cancer.ncbi, more
  • Chemicon mouse monoclonal anti-NeuN antibody (1:200) was used in immunohistochemistry to compare GDNF, BDNF, or both, for their capabilities to correct behavioral deficits and protect nigrostriatal dopaminergic neurons in a rat model of PD..ncbi, more
  • Upstate Biotechnology polyclonal HER-2 and phospho-HER-2 antibodies were used in western blot to study the inhibition EGFR family members in colon and breast cancer cellsncbi, more
  • Oncogene Research HER-2 mAb (Ab-3) was used in western blot and immunoprecipitation to study HER-2 down-regulation in colon cancer cellsncbi, more
  • Oncogene Research Products HER2 antibody was used in western blot to study gene regulation by anti-HER2 antibodyncbi, more
  • suppliernumreagent link
    Santa Cruz Biotechnology9HER2 antibody
    EMD Millipore4HER2 antibody
    Thermo Scientific Pierce Products3HER2 antibody
    Life Technologies Corporation2HER2 antibody
    Cell Signaling Technology6HER2 antibody
    Dako1HER2 antibody
    Nichirei Biosciences Inc.1
    Table 2. HER2 antibody western blot.
  • Oncogene Science HER-2 sandwich enzyme-linked immunosorbent assay kit was used to measure serum HER-2 concentrationncbi, more
Life Technologies CorporationLife Technologies Corporation HER2 product
  • Biosource anti-ErbB-2 antibody was used for western blot in order to investigate the role of Prdx1 in the regulation of tumorigenesis.ncbi, more
  • Zymed monoclonal mouse anti-human Her-2 antibody (clone TAB250) was used in immunohistochemistry to demonstrate whether overexpression of EMP3 in primary breast carcinoma is not associated with DNA methylationncbi, more
  • Invitrogen anti-total HER2 and anti-phospho-HER2 (Y1248) antibodies were used in western blot to investigate potential links between decreased BRCA1 levels and responses to Tam in ER-positive human breast cancer cell lines (T47D and ZR-75-1).ncbi, more
  • Zymed Laboratories anti-c-erbB-2 antibody was used in immunohistochemistry to investigate the relationship between amphiregulin expression and liver metastases of colorectal cancer.ncbi, more
  • suppliernumreagent link
    Santa Cruz Biotechnology3HER2 antibody
    Thermo Scientific Pierce Products2HER2 antibody
    Dako2HER2 antibody
    Biogenex1
    Genentech1
    Table 3. HER2 antibody immunocytochemistry.
Thermo Scientific Pierce ProductsThermo Scientific Pierce Products HER2 product
  • Neomarkers mouse anti-ERBB2 antibody (catalog no:Ab-17) was used in western blot to combine computational simulations, experimental testing of simulation results, and finally reverse engineering of a protein interaction network to define potential therapeutic strategies for de novo trastuzumab resistant breast cancerncbi, more
  • Neomarkers anti-HER2 monoclonal antibody was used in western blot and immunoprecipitation to study estrogen receptor alpha in breast cancer cellsncbi, more
  • Lab Vision four monoclonal ErbB2 antibodies, clone 9G6.10 and L87 + e2 4001 (against the extracellular domain), clone e2 4001 + 3B5, and NeoMarkers 1 (against the phosphorylated tyrosine 1248) were used in western blot and immunocytochemistry to study ErbB2 translocation in polarized epithelial cellsncbi, more
  • Neomarkers monoclonal and polyclonal anti-ErbB2 antibodies NM8, NM17, and NM1 were used in immunocytochemistry to study sialomucin complex (rat Muc4) and receptor tyrosine kinase ErbBs in the rat lacrimal gland.ncbi, more
  • NeoMarkers monoclonal ErbB2 Ab-4 antibody was used in immunoprecipitation to study growth factor-specific signaling pathway stimulation and gene expression mediated by ErbB receptors.ncbi, more
  • suppliernumreagent link
    Santa Cruz Biotechnology4HER2 antibody
    Thermo Scientific Pierce Products2HER2 antibody
    EMD Millipore1HER2 antibody
    Cell Signaling Technology1HER2 antibody
    Table 4. HER2 antibody immunoprecipitation.
  • Santa Cruz Biotechnology ErbB2 (9G6) antibody was used to carry out western blot and immunofluorescence staining analysis in order to investigate the signal cross talk between ErbB2 and PR receptor and the effect on breast cancer growth.ncbi, more
  • Santa Cruz Biotechnology ErbB-2 (C-18) and ErbB-2 (9G6) antibodes were used to carry out western blot, immunoprecipitation, and immunofluorescence staining analysis in order to investigate the signal cross talk between ErbB2 and PR receptor and the effect on breast cancer growth.ncbi, more
  • Santa Cruz anti-total HER2 and anti-phospho-HER2 (Y1248) antibodies were used in western blot to investigate potential links between decreased BRCA1 levels and responses to Tam in ER-positive human breast cancer cell lines (T47D and ZR-75-1).ncbi, more
  • Santa Cruz Biotechnology ERBB2 antibody was used in western blot in order to show that Hsp90 co-chaperone CDC37 can maintain the oncogenic protein kinase clients.ncbi, more
  • Santa Cruz Neu atibody was used in western blot to study the role of DecR1 in mammary tumor development.ncbi, more
  • suppliernum
    Genentech2
    Table 5. HER2 antibody block or activate.
  • Santa Cruz Biotechnology ErbB2 antibody was used in western blot and immunoprecipitation to study the molecular mechanisms downstream of BTC involved in mediating vascular remodeling.ncbi, more
  • Santa Cruz Biotechnology anti- ErbB2 (C-17) was used in western blot to examine ErbB2 expression levels in human bladder cancer cell lines 5637 and T24, T-47D breast cancer cells, Wild-type NIH 3T3 clone 7 mouse fibroblasts, as well as NIH 3T3 clone 7 fibroblasts overexpressing ErbB1, ErbB2, ErbB3, or ErbB4.ncbi, more
  • Santa Cruz Biotechnology anti-erbB2 antibody was used in immunocytochemistry, western blot, and immunoprecipitation to study that neuregulin-1 enhances motility and migration of human astrocytic glioma cells.ncbi, more
  • Santa Cruz Biotechnology anti-ErbB-2 antibody was used in western blot and immunoprecipitation to study that extracellular matrix enhances heregulin-dependent BRCA1 phosphorylation and suppresses BRCA1 expression through its C terminus.ncbi, more
WILEX Inc.
  • Oncogene anti-c-erbB-2 antibody (clone BP53.12) was used in immunohistochemistry to investigate the expressions of EGFR and pEGFR and their correlation with overall and disease-free survival, clinicopathological parameters and biological markers of invasion and angiogenesis.ncbi, more
  • suppliernumreagent link
    EMD Millipore1HER2 antibody
    Table 6. HER2 antibody ELISA.
  • Cell Signaling Technology phospho-ErbB2 (Tyr 1221/1222) phospho-ErbB-2 (Tyr 877) antibodies were used to carry out western blot analysis in order to investigate the cross talk between ErbB2 and PR receptor signaling and the effect on stat3 activation and breast cancer growth.ncbi, more
  • Cell Signaling rabbit anti-pHER2 antibody was used to perform immunohistochemistry in order to study the function of the fixative in the immunohistochemical detection of phosphoproteins.ncbi, more
  • Cell Signaling Technology anti-phospho HER2 (Tyr1221/1222) antibody (1:1000) was used in western blot in order to study the efficacy of lapatinib for preventing the outgrowth of breast cancer cells in the brain in a mouse xenograft model of brain metastasisncbi, more
  • Cell Signaling Technology anti-HER2 antibody (1:1000) was used in western blot in order to study the efficacy of lapatinib for preventing the outgrowth of breast cancer cells in the brain in a mouse xenograft model of brain metastasisncbi, more
  • Cell Signaling rabbit polyclonal HER2 antibody was used in western blot at 1:1000 dilution in order to demonstrate a functional cross-talk between AR and ErbB2 pathwaysncbi, more
  • Cell Signaling Tyr877-ErbB2 antibody was used in western blot and immunoprecipitation to study the molecular mechanisms downstream of BTC involved in mediating vascular remodeling.ncbi, more
  • Cell Signaling Technology rabbit polyclonal anti-HER-2/ErbB2 antibody was used in western blot to study expression of p53, ErbB1, ErbB2, and Raf-1 in lung cancer.ncbi, more
  • Dako polyclonal rabbit antihuman c-erbB-2 antibody (Cytomation EnVision A0485 affinity isolated/10 dilution) was used to perform immunohistochemistry in order to investigate the effects of c-erbB-2 expression on endometrial carcinomas.ncbi, more
  • Dako HER2 antibody was used to perform immunohistochemistry in order to clarify that high CENP-F expression was the prognostic indicator of primary breast cancer.ncbi, more
  • DAKO monoclonal anti-HER2 antibody was used in immunohistochemistry to identify biomarkers in ductal carcinoma in situ of the breast with microinvasion in paraffin sections from human tumor.ncbi, more
  • DAKO anti-HER2 was used to perform immunohistochemistry at 1:400 dilution in order to show that the ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) was identified as a a novel human breast tumour marker.ncbi, more
  • DAKO rabbit polyclonal anti-HER2 antibody (A0485) was used in immunohistochemistry to study the association of the CD44+/CD24- phenotype to basal-like and BRCA1 hereditary breast cancer in sections from human tumor.ncbi, more
  • Dako Cytomation rabbit anti-PgR(A0485, 1/800) antibody was used to perform immunohistochemistry in order to study the correlation between the pathologic type of breast cancer and the overexpressed and altered localized atypical protein kinase C lambda/iota.ncbi, more
  • Dako rabbit anti-Her2/neu antobody was used in immunohistochemistry at 1:8,000 in order to study the expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancerncbi, more
  • DAKO polyclonal HER2 antibody (1:2000) was used in immunohistochemistry in order to investigate the predictive value of clinical and biological markers for a pathological complete remission after a preoperative dose-dense regimen of doxorubicin and docetaxel, with or without tamoxifen, in primary operable breast cancerncbi, more
  • Dako rabbit polyclonal anti-HER2 antibody was used to perform immunohistochemistry in order to study the DNA and the protein level of HER1-HER4 in 278 breast cancer patients.ncbi, more
  • DakoCytomation anti-HER2 antibody (1:1000) was used to perform immunohistochemistry in order to study the expression of CRYAB in breast carcinomas.ncbi, more
  • Dako North America anti-Her2neu antibody (CB11) was used in paraffin sections from human breast cancer and in immunohistochemistry to study the role for IL-6 in driving Stat3 activation in breast cancer.ncbi, more
  • Dako rabbit polyclonal HER-2/neu antibody was used in immunohistochemistry to study the expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.ncbi, more
  • Dako polyclonal anti-HER-2/neu antibody was used in immunohistochemistry to detect HER-2/neu in adjacent serial sections of two breast invasive ductal carcinomas from patients.ncbi, more
  • DAKO rabbit polyclonal antibody for human epidermal growth factor receptor 2 (HER2; clone A0485) was used in immunohistochemistry to study the biological significance of estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor.ncbi, more
  • AKO rabbit polyclonal anti-HER2/neu (anti-c-erbB-2) antibody was used in immunohistochemistry o study HER2/neu overexpression in breast cancer patientsncbi, more
  • DAKO monoclonal anti-HER2 antibody was used in immunohistochemistry to study whether levels of ANX7 correlate with breast cancer progression and survival in paraffin sections from human tumor.ncbi, more
  • DAKO anti-HER2 polyclonal antibody was used in immunohistochemistry to study the tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology.ncbi, more
  • Dako rabbit polyclonal anti-HER2/neu protein antibody (clone Mib-1) was used in paraffin sections from human cancer and in immunohistochemistry to study the effect of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers.ncbi, more
  • DakoCytomation polyclonal ErbB2 antibody was used in immunocytochemistry to study ErbB2 translocation in polarized epithelial cellsncbi, more
  • DAKO anti-Her2/neu antibody was used in immunohistochemistry to study expression of cytokeratin 17 and/or cytokeratin 5/6 in tumor cells.ncbi, more
  • Dako polyclonal anti-ErbB2 antibody was used in western blot and immunocytochemistry to study sialomucin complex (rat Muc4) and receptor tyrosine kinase ErbBs in the rat lacrimal gland.ncbi, more
CARPINTERIA
  • Carpinteria monoclonal Her-2/neu antibody was used in immunohistochemistry in order to evaluate the expression of EGFR in a series of 16 gallbladder cancer patients from North Americancbi, more
Biogenex
  • BioGenex mouse monoclonal HER2 antibody (CB-11) was used in immunohistochemistry and immunocytochemistry to study the expression of activated ERK1/2 in head and neck squamous carcinoma and their relationship with EGF receptor/TGF-alpha expression.ncbi, more
Nichirei Biosciences Inc.
  • Nichirei rabbit anti-c-erbB-2 polyclonal antibody was used in western blot and immunohistochemistry to study the frequent co-Localization of cox-2 and laminin-5 2 chain at the invasive front of early-stage lung adenocarcinomas.ncbi, more
Leica Microsystems
  • Novocastra anti-c-erbB-2 monoclonal antibody was used to perform immunohistochemistry in order to study the correlation of EGF and EGFR with metastasis of pancreatic ductal carcinoma.ncbi, more
  • NovoCastra anti-HER2/neu antibody CB11 was used in immunohistochemistry to study the association of alpha-Methylacyl-CoA racemase protein expression with the degree of differentiation in breast cancer.ncbi, more
  • Novocastra monoclonal anti-HER-2/neu antibody was used in immunohistochemistry to detect HER-2/neu in adjacent serial sections of two breast invasive ductal carcinomas from patients.ncbi, more
  • Novocastra CB11 HER2 antibody was used in immunohistochemistry to study ovarian cancers in BRCA1 and BRCA2 carriersncbi, more
  • NovoCastra anti-c-erbB2 antibody (clone CB11) was used in tissue sections from human and in immunohistochemistry to study the cell cycle regulation in patients with IM at the GOJ.ncbi, more
  • Novocastra monoclonal anti-ErbB2 antibody (NCL-CB11) was used in immunohistochemistry to detect the localization of ErbB2 in human transitional cell carcinoma (TCC) of the urinary bladder and histologically normal regions of urinary bladders from patients with prostate cancer, as well as in clone 7 mouse NIH 3T3 cells as positive and negative controls.ncbi, more
  • NovoCastra monoclonal anti-c-erbB-2 antibody was used in immunohistochemistry to study CD1d and invariant NKT cells at the human maternal-fetal interface.ncbi, more
Roche Applied Science
  • Ventana anti-HER2 antibody was used to perform immunohistochemistry in order to study the signification of the expression of CD109 in basal-like breast carcinoma.ncbi, more
  • Ventana Medical Systems rabbit polyclonal anti-HER-2 antibody was used in paraffin sections from human breast cancer and in immunohistochemistry to study the role of 17 estradiol for down-regulation of Cap43/NDRG1/Drg-1 in human breast cancer cells.ncbi, more
Genentech
  • Genentech monoclonal anti-HER2 antibody Herceptin was used as contorl antibody in antibody blocking experiments to investigate the role of PI3k/Akt pathway in macrophage-mediated antibody-dependent cell-mediated cytotoxicity.ncbi, more
  • Genentech anti-HER2 murine monoclonal antibody 4D5 and humanized monoclonal antibody trastuzumab (Herceptin) were used in blocking expriments to study gene regulation by anti-HER2 antibodyncbi, more
  • Genentech anti-ErbB2 antibody 3E8 was used in immunocytochemistry to identify the leucine-rich repeat protein LRIG1 as a negative regulator of ErbB family receptor tyrosine kinases.ncbi, more
Articles Reviewed
  1. Aylin Ege Gul et al. (2010). "The relationship of cerb B 2 expression with estrogen receptor and progesterone receptor and prognostic parameters in endometrial carcinomas".PMID 20167054
  2. Juxiang Cao et al. (2009). "Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity".PMID 19369943
  3. Wei Zhou et al. (2009). "EMP3 overexpression in primary breast carcinomas is not associated with epigenetic aberrations".PMID 19270820
  4. Trupti Joshi et al. (2009). "The PtdIns 3-kinase/Akt pathway regulates macrophage-mediated ADCC against B cell lymphoma".PMID 19148288
  5. Ozgur Sahin et al. (2009). "Modeling ERBB receptor-regulated G1/S transition to find novel targets for de novo trastuzumab resistance".PMID 19118495
  6. Cecilia J Proietti et al. (2009). "Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth".PMID 19103753
  7. Shigeto Ueda et al. (2008). "Expression of centromere protein F (CENP-F) associated with higher FDG uptake on PET/CT, detected by cDNA microarray, predicts high-risk patients with primary breast cancer".PMID 19102762
  8. Janine A Burns et al. (2009). "Choice of fixative is crucial to successful immunohistochemical detection of phosphoproteins in paraffin-embedded tumor tissues".PMID 19001637
  9. J Wen et al. (2009). "Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions".PMID 18997820
  10. J R Smith et al. (2009). "Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitors".PMID 18931700
  11. Yasuhiro Okumura et al. (2008). "Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion".PMID 18837981
  12. Matthew Kaufman et al. (2008). "EGFR expression in gallbladder carcinoma in North America".PMID 18825277
  13. Brunilde Gril et al. (2008). "Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain".PMID 18664652
  14. Nuran Bektas et al. (2008). "The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer".PMID 18627608
  15. Gabriella Honeth et al. (2008). "The CD44+/CD24- phenotype is enriched in basal-like breast tumors".PMID 18559090
  16. Yasuyuki Kojima et al. (2008). "The overexpression and altered localization of the atypical protein kinase C lambda/iota in breast cancer correlates with the pathologic type of these tumors".PMID 18538170
  17. Christina Magkou et al. (2008). "Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas".PMID 18522728
  18. Ali Naderi et al. (2008). "A functionally significant cross-talk between androgen receptor and ErbB2 pathways in estrogen receptor negative breast cancer".PMID 18516291
  19. Anna Pryczynicz et al. (2008). "Expression of EGF and EGFR strongly correlates with metastasis of pancreatic ductal carcinoma".PMID 18505086
  20. Yasmine Nadler et al. (2008). "Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer".PMID 18430249
  21. Masaki Hasegawa et al. (2008). "CD109 expression in basal-like breast carcinoma".PMID 18429827
  22. Michiyo Yamada et al. (2008). "Amphiregulin is a promising prognostic marker for liver metastases of colorectal cancer".PMID 18413824
  23. Gunter von Minckwitz et al. (2008). "Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast".PMID 18380893
  24. Andrea Sassen et al. (2008). "Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients".PMID 18182100
  25. Stephanie M Sitterding et al. (2008). "AlphaB-crystallin: a novel marker of invasive basal-like and metaplastic breast carcinomas".PMID 18164413
  26. Josie Ursini-Siegel et al. (2007). "Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development".PMID 17636013
  27. Marjan Berishaj et al. (2007). "Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer".PMID 17531096
  28. David L Shattuck et al. (2007). "LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy".PMID 17178829
  29. Lily Yen et al. (2006). "Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth".PMID 17145873
  30. Abbas Fotovati et al. (2006). "17Beta-estradiol induces down-regulation of Cap43/NDRG1/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells".PMID 16707596
  31. Mei Sun et al. (2005). "Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease".PMID 16018990
  32. Agnieszka K Witkiewicz et al. (2005). "Alpha-methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis".PMID 15941950
  33. Hu Xu et al. (2005). "Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells".PMID 15767552
  34. Scott K Kuwada et al. (2005). "Integrin alpha5/beta1 expression mediates HER-2 down-regulation in colon cancer cells".PMID 15757908
  35. Dafydd G Thomas et al. (2005). "Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma".PMID 15641030
  36. Xiao Feng Le et al. (2005). "Genes affecting the cell cycle, growth, maintenance, and drug sensitivity are preferentially regulated by anti-HER2 antibody through phosphatidylinositol 3-kinase-AKT signaling".PMID 15504738
  37. Vanesa Gregorc et al. (2004). "Effects of gefitinib on serum epidermal growth factor receptor and HER2 in patients with advanced non-small cell lung cancer".PMID 15447984
  38. Majida Esslimani-Sahla et al. (2004). "Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer".PMID 15355905
  39. Melanie B Laederich et al. (2004). "The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases".PMID 15345710
  40. Takashi Suzuki et al. (2004). "Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor".PMID 15231680
  41. Weiya Xia et al. (2004). "Phosphorylation/cytoplasmic localization of p21Cip1/WAF1 is associated with HER2/neu overexpression and provides a novel combination predictor for poor prognosis in breast cancer patients".PMID 15173090
  42. Zhibo Yang et al. (2004). "Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor alpha in breast cancer cells".PMID 15173068
  43. Mizuo Mifune et al. (2004). "Signal transduction of betacellulin in growth and migration of vascular smooth muscle cells".PMID 15163624
  44. Sunil R Lakhani et al. (2004). "Pathology of ovarian cancers in BRCA1 and BRCA2 carriers".PMID 15073127
  45. Meera Srivastava et al. (2004). "Prognostic impact of ANX7-GTPase in metastatic and HER2-negative breast cancer patients".PMID 15073110
  46. N J Trudgill et al. (2003). "Cell cycle regulation in patients with intestinal metaplasia at the gastro-oesophageal junction".PMID 14645692
  47. Teemu T Junttila et al. (2003). "Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients".PMID 14614020
  48. Torsten O Nielsen et al. (2003). "Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology".PMID 14507652
  49. Andrea Decensi et al. (2003). "A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers".PMID 12783932
  50. Victoria P Ramsauer et al. (2003). "Muc4/sialomucin complex, the intramembrane ErbB2 ligand, translocates ErbB2 to the apical surface in polarized epithelial cells".PMID 12748185
  51. Patricia A Ritch et al. (2003). "Neuregulin-1 enhances motility and migration of human astrocytic glioma cells".PMID 12600989
  52. Tiho Miralem et al. (2003). "Extracellular matrix enhances heregulin-dependent BRCA1 phosphorylation and suppresses BRCA1 expression through its C terminus".PMID 12509456
  53. Matt van de Rijn et al. (2002). "Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome".PMID 12466114
  54. Jonathan E Boyson et al. (2002). "CD1d and invariant NKT cells at the human maternal-fetal interface".PMID 12368486
  55. Xiaodan Yu et al. (2002). "Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228".PMID 11929951
  56. Toshiro Niki et al. (2002). "Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas".PMID 11891209
  57. M E Arango et al. (2001). "Production and localization of Muc4/sialomucin complex and its receptor tyrosine kinase ErbB2 in the rat lacrimal gland".PMID 11687512
  58. J Albanell et al. (2001). "Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments".PMID 11522647
  59. C Sweeney et al. (2001). "Growth factor-specific signaling pathway stimulation and gene expression mediated by ErbB receptors".PMID 11297548